Investment Thesis
Glucose Health exhibits technical insolvency with negative stockholders equity of -$426.2K against minimal assets of $26.4K, coupled with negative operating cash flow and critically inadequate liquidity. The company cannot meet short-term obligations (current ratio 0.06x) and burns cash operationally despite marginal revenue. Most critically, financial data is stale (Sept 2017), suggesting company inactivity or abandonment.
Strengths
- Gross margin of 78.5% indicates product-level profitability when revenue is generated
- Extreme revenue growth of 7232% YoY demonstrates demand response from minimal base
- Minimal debt burden with no long-term debt obligations
Risks
- Technical insolvency: negative equity of -$426.2K indicates liabilities exceed assets by material amount
- Critical liquidity crisis: current ratio of 0.06x means company cannot cover short-term obligations
- Negative operating cash flow of -$13.9K with only $16.6K cash reserves indicates unsustainable burn rate
- Financial data is 9 years old (Sept 2017), indicating company abandonment or dormancy
- Net income positivity appears driven by non-operating items, not sustainable operations
- Micro-scale revenue base of $72.9K provides no margin for error
Key Metrics to Watch
- Stockholders equity trajectory and path to positive territory
- Operating cash flow sustainability and monthly burn rate
- Current liquidity position and ability to meet liabilities
- Revenue stability and customer retention post-growth spike
Financial Metrics
Revenue
72.9K
Net Income
39.0K
EPS (Diluted)
$0.00
Free Cash Flow
-13.9K
Total Assets
26.4K
Cash
16.6K
Profitability Ratios
Gross Margin
78.5%
Operating Margin
-10.4%
Net Margin
53.5%
ROE
N/A
ROA
148.1%
FCF Margin
-19.1%
Balance Sheet & Liquidity
Current Ratio
0.06x
Quick Ratio
0.06x
Debt/Equity
N/A
Debt/Assets
1,717.4%
Interest Coverage
-0.66x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-10T13:45:25.524095 |
Data as of: 2017-09-30 |
Powered by Claude AI